Editing: “With A Reported ~$3B Invested In HealthTech In 2016, Asia Currently Ranks Number Two Globally!” https://t.co/FVfKGkFZ4X — The Propell Group (@ThePropellGroup) March 1, 2017 #healthtech
Global Healthcare | 17 Deals, Investments & Transactions | Week 8 – Feb 2017 https://t.co/zf9oWvB9Tc — The Propell Group (@ThePropellGroup) March 1, 2017 #healthtech
Grapeless Wine And Cowless Milk: 60+ Synthetic Biology Startups In A Market Map https://t.co/19HBVW1y14 — The Propell Group (@ThePropellGroup) March 1, 2017 #healthtech
Genomics promises a leap forward for rare disease diagnosis https://t.co/CJrR13ljt4 via @FT — The Propell Group (@ThePropellGroup) March 1, 2017 #healthtech
“Global Healthcare | 17 Deals, Investments & Transactions | Week 8 – Feb 2017” https://t.co/Ghhxfon4ka by @ThePropellGroup — The Propell Group (@ThePropellGroup) February [...]
With A Reported ~$3B Invested In HealthTech In 2016, Asia Currently Ranks Number Two Globally! https://t.co/RAH0tWO8C3 — The Propell Group (@ThePropellGroup) February 28, 2017 #healthtech
HealthTech in Vietnam: Reflections from Three Years on the Ground – Galen Growth Asia https://t.co/M90D3hzG3G — The Propell Group (@ThePropellGroup) February 28, 2017 #healthtech
Medical Device Acquisitions Fall After Capstone Year In 2015 https://t.co/FADbZFlya5 — The Propell Group (@ThePropellGroup) February 28, 2017 #healthtech
GSK ‘real world’ study offers new model for drug trials https://t.co/5CfV9LSjCW via @FT — The Propell Group (@ThePropellGroup) February 27, 2017 #healthtech
Kimchi and hypochondria keep South Koreans healthy https://t.co/30I1mq1JRQ via @FT — The Propell Group (@ThePropellGroup) February 26, 2017 #healthtech